.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Current and Future Trends in Myelofibrosis: Cytopenias

EP. 1: Dr. Kuykendall on the Potential for Momelotinib in Myelofibrosis

November 2nd 2021

Andrew T. Kuykendall, MD, discusses the potential for momelotinib in the treatment of patients with myelofibrosis.

EP. 2: Dr. Harrison on the Current State of Treatment in Myelofibrosis

December 1st 2021

Claire Harrison, MD, FRCP, FRCPath, discusses the current state of treatment in myelofibrosis.

EP. 3: Current and Future Trends in Myelofibrosis: Cytopenias

December 13th 2021

This publication reviews challenges associated with the management of myelofibrosis and examines the current and future role of janus-associated kinase inhibitors in the evolving treatment landscape.